自身免疫性中性粒细胞减少症的临床试验
总计13056个结果
-
Malaghan Institute of Medical Research招聘中
-
Centre Hospitalier Universitaire VaudoisUniversity Hospital, Basel, Switzerland完全的
-
Spectrum Pharmaceuticals, Inc完全的
-
EVIVE BiotechnologySun Yat-sen University; Fudan University完全的
-
EVIVE BiotechnologyZhejiang Cancer Hospital; Fudan University; RenJi Hospital; Henan Cancer Hospital; Tongji Hospital; The... 和其他合作者完全的
-
Korea Cancer Center HospitalSamsung Medical Center; Pusan National University Hospital; Asan Medical Center; Seoul National... 和其他合作者未知
-
National Institute of Allergy and Infectious Diseases...完全的
-
Academisch Ziekenhuis MaastrichtZonMw: The Netherlands Organisation for Health Research and Development完全的
-
Assistance Publique - Hôpitaux de ParisHoffmann-La Roche完全的
-
University of California, San FranciscoNational Cancer Institute (NCI)完全的
-
Oslo University HospitalUllevaal University Hospital; Sorlandet Hospital HF; Sykehuset Innlandet HF; The Hospital of Vestfold 和其他合作者完全的癌症 | 中性粒细胞减少症 | 发烧
-
Centre Francois Baclesse完全的中性粒细胞减少症 | 未明确的成人实体瘤,特定方案 | 化疗药物毒性法国
-
Khon Kaen UniversityNational Research Council of Thailand完全的癌症 | 中性粒细胞减少症 | 发烧
-
Burnasyan Federal Medical Biophysical Center未知
-
Sorveglianza Epidemiologica Infezioni Fungine Emopatie...完全的
-
Lawson Health Research InstituteApobiologix.尚未招聘淋巴瘤 | 多发性骨髓瘤 | 发热性中性粒细胞减少症 | 订婚,耐心
-
Assistance Publique Hopitaux De Marseille未知Sepsis in Neutropenic Patients法国
-
Janssen Pharmaceutical K.K.完全的真菌病 | 念珠菌病 | 中性粒细胞减少症 | 曲霉病 | 隐球菌病 | 组织胞浆菌病 | 芽生菌病日本
-
Tasso Inc.The Leukemia and Lymphoma Society尚未招聘
-
Swiss Pediatric Oncology GroupBayer; GlaxoSmithKline; Swiss Cancer League终止
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的腹泻 | 大肠癌 | 中性粒细胞减少症美国, 加拿大, 波多黎各
-
Enzon Pharmaceuticals, Inc.撤销血液病 | 癌症 | 中性粒细胞减少症 | 发烧
-
HealthCore-NERINational Heart, Lung, and Blood Institute (NHLBI)完全的
-
Tianjin Medical University Cancer Institute and...Chia Tai Tianqing Pharmaceutical Group Co., Ltd.尚未招聘
-
Teva Branded Pharmaceutical Products R&D, Inc.完全的侵袭性 B 细胞非霍奇金淋巴瘤具有 R-CHOP-21 诱导的中性粒细胞减少症的高风险德国, 意大利, 西班牙